• / Free eNewsletters & Magazine
  • / My Account
Home>Global Biosensors for Point-of-Care Testing Technologies, Applications, Forecasts 2017-2027 - Research and Markets

Global Biosensors for Point-of-Care Testing Technologies, Applications, Forecasts 2017-2027 - Research and Markets

Global Biosensors for Point-of-Care Testing Technologies, Applications, Forecasts 2017-2027 - Research and Markets

09/28/2017

Global Biosensors for Point-of-Care Testing Technologies, Applications, Forecasts 2017-2027 - Research and Markets

The "Biosensors for Point-of-Care Testing: Technologies, Applications, Forecasts 2017-2027" report has been added to Research and Markets' offering.

The point-of-care biosensors will become a $33 billion market by 2027, with molecular diagnostic devices the main driver for this growth.

This report gives a complete analysis of the important trends in the field of medical biosensors, and lists the new technologies and devices which are likely to be highly disruptive to the in vitro diagnostics market.

Biosensors are used to detect and quantify biological material associated with a disease state or health condition (biomarkers). Biosensors are therefore powerful tools for diagnosis and monitoring. As technological advances allow for such tests to be conducted faster and on smaller devices, these tests are moving out of specialised laboratories and closer to the patient at the point-of-care.

Medical biosensors can diagnose a wealth of diseases and health conditions, such as diabetes, cardiovascular issues, infectious diseases and cancer. Increasingly, biosensors are also being used to achieve targeted therapies in precision medicine and increase the efficacy of drugs through pharmacogenomics.

This report is the first to comprehensively look at all commercial applications for point-of-care biosensors. It gives you a complete picture of the types of biosensors, the key players on the market and the emerging technologies.

In this report, 'point-of-care' is defined as being portable and able to gives results in under one hour. Commercial biosensors are described in four categories:

©2017 Morningstar Advisor. All right reserved.